In the suburbs of Cambridge, scientists are tracking the spread of the new variant virus. Scientists have discovered that the new variant virus is not only easier to spread, but also more deadly than the earlier forms of the virus.
Genetic analysis of virus samples showed that the South African variant virus has been detected in at least 44 people in the UK, which can evade antibodies.
On January 25, local time, the American pharmaceutical company Moderna announced that its vaccines are effective against the British variant virus and the South African variant virus.
After the announcement, as of the day’s close, Moderna’s stock price rose 12.2%. On January 26, Moderna’s stock price has risen to $151.93.
The results of Moderna’s in-house laboratory research show that the British variant virus does not affect the effectiveness of the vaccine, but the South African variant virus reduces the vaccine’s ability to neutralize antibodies to 1/6. However, the company still believes that as long as two doses of vaccine are injected, enough vaccine can be provided. Of antibody protection.
However, Moderna said that out of caution, the company added a booster shot to the vaccine portfolio, which means that a total of three shots of vaccine are required.
The World Health Organization has stated that it supports the postponement of the second dose of the new crown vaccine in some cases, with an interval of up to 6 weeks. In addition, the WHO also warned that pregnant women should not receive Moderna’s new crown vaccine.
The vaccine is less effective against the South African variant virus, and Moderna is developing an enhanced version of the vaccine. Click on the video to have a look!
– .
